Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-022862

CHIEF OPERATING OFFICER gave up 1,899 shares (to pay taxes)

  • CHIEF OPERATING OFFICER acquired 6,463 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2024-09-01 Option exercise +4,499 124,410 D
Tessari Eben CHIEF OPERATING OFFICER 2024-09-01 Shares withheld for taxes −1,322 $26.74 $35,350 123,088 D
Tessari Eben CHIEF OPERATING OFFICER 2024-09-02 Option exercise +1,964 125,052 D
Tessari Eben CHIEF OPERATING OFFICER 2024-09-02 Shares withheld for taxes −577 $26.74 $15,429 124,475 D
Derivatives
Tessari Eben CHIEF OPERATING OFFICER 2024-09-01 Grant or award · Restricted Share Unit +6,981 6,981 D
Tessari Eben CHIEF OPERATING OFFICER 2024-09-01 Grant or award · Share Option +36,300 36,300 D
Tessari Eben CHIEF OPERATING OFFICER 2024-09-01 Option exercise · Restricted Share Unit −2,726 5,452 D
Tessari Eben CHIEF OPERATING OFFICER 2024-09-01 Option exercise · Restricted Share Unit −1,773 5,318 D
Tessari Eben CHIEF OPERATING OFFICER 2024-09-02 Option exercise · Restricted Share Unit −1,964 1,964 D
Loading xslF345X05/form4-09052024_120923.xml…